Citation Impact
Citing Papers
Human cerebral organoids recapitulate gene expression programs of fetal neocortex development
2015 StandoutNobel
A definition and classification of status epilepticus – Report of the ILAE Task Force on Classification of Status Epilepticus
2015 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
FMR1 and the fragile X syndrome: Human genome epidemiology review
2001
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
Heparin Binding and Oligomerization of Hepatocyte Growth Factor/Scatter Factor Isoforms
1997
MECP2 disorders: from the clinic to mice and back
2015
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Genetic Variation and Recent Positive Selection in Worldwide Human Populations: Evidence from Nearly 1 Million SNPs
2009
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
2009
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
2007 StandoutNobel
Coming to Terms With Risk Factors for Eating Disorders: Application of Risk Terminology and Suggestions for a General Taxonomy.
2004
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
2010 StandoutNobel
Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient
2009
Perioperative Management of Antithrombotic Therapy
2012 Standout
Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: Differences between restricting and bingeing/purging subtypes
2003
The molecular basis of human retinal and vitreoretinal diseases
2010 Standout
Oral Anticoagulant Therapy
2012 Standout
Drug Studies on Rett Syndrome: From Bench to Bedside
2020
Antithrombotic Therapy for VTE Disease
2016 Standout
Vascular changes in the cerebellum of Norrin /Ndph knockout mice correlate with high expression of Norrin and Frizzled‐4
2008
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
COVID-19: A promising cure for the global panic
2020 Standout
Are eating disorders culture-bound syndromes? Implications for conceptualizing their etiology.
2003
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
CYP2C9 Genotype-guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study
2007
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
Tissue Plasminogen Activator Contributes to the Late Phase of LTP and to Synaptic Growth in the Hippocampal Mossy Fiber Pathway
1998 StandoutNobel
Targeting the Met signaling pathway in renal cancer
2009
VKORC1: molecular target of coumarins
2007
Widespread Translational Remodeling during Human Neuronal Differentiation
2017 StandoutNobel
A genotyping method for VKORC1 1173C>T by Pyrosequencing®technology
2008 StandoutNobel
Epidemiology of Eating Disorders: Incidence, Prevalence and Mortality Rates
2012 Standout
The weirdest people in the world?
2010 Standout
Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c‐Met system via hypoxia inducible factor‐1 in pancreatic cancer
2008
Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product
1993
Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo
1998 StandoutNobel
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Activation of Hepatocyte Growth Factor in the Injured Tissues Is Mediated by Hepatocyte Growth Factor Activator
1996
Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy
2009
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
How culture shaped the human genome: bringing genetics and the human sciences together
2010 Standout
Cancer as an evolutionary and ecological process
2006 Standout
FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders
2015
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records
2006 StandoutNobel
Electroencephalographic criteria for nonconvulsive status epilepticus: Synopsis and comprehensive survey
2012
Mining electronic health records: towards better research applications and clinical care
2012 Standout
DNA methylation and human disease
2005 Standout
Genetic Determinants of Response to Warfarin during Initial Anticoagulation
2008
Homeostasis of Eye Growth and the Question of Myopia
2004 Standout
The past, the future and the biology of memory storage
1999 StandoutNobel
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Estimating Allele Age
2000
Influence of CYP2C9 and VKORC1 on Warfarin Dose, Anticoagulation Attainment and Maintenance Among European–Americans and African–Americans
2008
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
1997 StandoutScience
Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon
2008
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
Guidelines for the Primary Prevention of Stroke
2014 Standout
Degradation of the Met Tyrosine Kinase Receptor by the Ubiquitin-Proteasome Pathway
1997 StandoutNobel
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Improved Oral Anticoagulation After a Dietary Vitamin K–Guided Strategy
2009
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
2009
Hepatocyte Growth Factor (HGF)/NK1 Is a Naturally Occurring HGF/Scatter Factor Variant with Partial Agonist/Antagonist Activity
1996
Liver Regeneration
1997 StandoutScience
CYP2C9*8 is Prevalent Among African–Americans: Implications for Pharmacogenetic Dosing
2009
Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration
1995
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Expression of Hepatocyte Growth Factor/Scatter Factor, Its Receptor,c-met, and Tissue-Type Plasminogen Activator during Development of the Murine Olfactory System
1996
Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.
1993
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
1999 Standout
In vivo response of hepatocytes to growth factors requires an initial priming stimulus
1994
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
2009 StandoutScience
Differences and similarities between human and chimpanzee neural progenitors during cerebral cortex development
2016 StandoutNobel
Objectification Theory and Psychology of Women: A Decade of Advances and Future Directions
2008 Standout
Works of Eva Gak being referenced
Novel FOXG1 mutations associated with the congenital variant of Rett syndrome
2009
Combined genetic profiles of components and regulators of the vitamin K-dependent γ-carboxylation system affect individual sensitivity to warfarin
2006
Screening for fragile X syndrome in women of reproductive age
2000
Epilepsy in Rett syndrome—The experience of a National Rett Center
2010
Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9
2005
Association between anorexia nervosa and the hsKCa3 gene: a family-based and case control study
2002
Processing of hepatocyte growth factor to the heterodimeric form is required for biological activity
1992
Ex Vivo Treatment with a Novel Synthetic Aminoglycoside NB54 in Primary Fibroblasts from Rett Syndrome Patients Suppresses MECP2 Nonsense Mutations
2011
A novel missense mutation in the NDP gene in a child with Norrie disease and severe neurological involvement including infantile spasms
2007
CAG repeat polymorphism within the KCNN3 gene is a significant contributor to susceptibility to anorexia nervosa: A case‐control study of female patients and several ethnic groups in the Israeli Jewish population
2004
The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome
2009
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance
2006
Could the 185delAG BRCA1 Mutation Be an Ancient Jewish Mutation?
1997
Could the 185delAG BRCA1 mutation be an ancient Jewish mutation?
1998
VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals
2008